Valeria Santini
University of Florence
AOU Careggi
Firenze
Italy. Electronic address:
Name/email consistency: high
- Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietins. Santini, V. Semin. Hematol. (2012)
- Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Santini, V., Alessandrino, P.E., Angelucci, E., Barosi, G., Billio, A., Di Maio, M., Finelli, C., Locatelli, F., Marchetti, M., Morra, E., Musto, P., Visani, G., Tura, S. Leuk. Res. (2010)
- Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes. Santini, V. Expert. Rev. Hematol (2009)
- Azacitidine in lower-risk myelodysplastic syndromes. Santini, V. Leuk. Res. (2009)
- Treatment options in myelodysplastic syndromes: a new frontier. Santini, V., Gozzini, A., Bosi, A. J. Chemother (2008)
- Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Santini, V., Gozzini, A., Ferrari, G. Curr. Drug Metab. (2007)
- The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal. Santini, V., Scappini, B., Indik, Z.K., Gozzini, A., Ferrini, P.R., Schreiber, A.D. Blood (2003)
- Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647. Santini, V., Scappini, B., Grossi, A., Gozzini, A., Bonsi, L., Pagliai, G., Rossi Ferrini, P., Bagnara, G.P. Haematologica (2002)
- Amifostine: chemotherapeutic and radiotherapeutic protective effects. Santini, V. Expert. Opin. Pharmacother (2001)
- Searching for the magic bullet against cancer: the butyrate saga. Santini, V., Gozzini, A., Scappini, B., Grossi, A., Rossi Ferrini, P. Leuk. Lymphoma (2001)
- Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation. Santini, V., Gozzini, A., Scappini, B., Rossi Ferrini, P. Haematologica (1999)
- Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells. Santini, V., Gozzini, A., Scappini, B., Caporale, R., Zoccolante, A., Rigacci, L., Gelardi, E., Grossi, A., Alterini, R., Ferrini, P.R. Haematologica (1999)
- The potential of amifostine: from cytoprotectant to therapeutic agent. Santini, V., Giles, F.J. Haematologica (1999)